This afternoon, the Trump administration released Executive Orders focused on pharmaceutical pricing. Solving this crisis and delivering real change will require elected officials and health care stakeholders to develop practical, informed, and market-based solutions that make health care and prescription drugs more affordable and accessible to all Americans.
AMCP submitted comments on a CMS proposed rule making changes to the Medicaid Drug Rebate Program to account for prescription drug value-based purchasing arrangements.
Learn about the latest health care trends and the impact of COVID-19. Here, AMCP CEO Susan A. Cantrell, RPh, CAE, highlights important analysis from last week’s webinar featuring Doug Long, vice president of industry relations at IQVIA.
Sponsored webinar that reviewed the Global Initiative for Obstructive Disease (GOLD) 2020 report that states COPD is a treatable disease and highlights two specific treatable traits, which may impact various areas of disease burden.
AMCP joined with other national pharmacy stakeholders to urge HHS to authorize pharmacists to order and administer COVID-19 vaccines when they become available.